Thanks for the analysis. HCT is stated for treatment of Surrogate (Feline coronavirus ) - per 20 April 2020 twitter redaction, not Surrogate Human coronavirus 229E, any idea if they are planning on targeting Human coronavirus 229E as well and hence might get wider treatment announcement?
TGA https://www.tga.gov.au/surrogate-viruses-use-disinfectant-efficacy-tests-justify-claims-against-covid-19
Phenomenal Growth @Successful UK Lab tests +, page-42
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.286M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 375610 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 75000 | 1 |
View Market Depth
| Last trade - 16.12pm 13/11/2024 (20 minute delay) ? |
| HCT (ASX) Chart |
Day chart unavailable